Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Evidence-Based Mental Health
|
April 14, 2016
Long-acting injectable risperidone as an option in first-episode psychosis
Nancy H Covell
Evidence-Based Mental Health
|
January 30, 2009
Antipsychotic medications do not differ substantially in ability to reduce violent behaviour in people with schizophrenia
Nancy H Covell
Psychiatric Services (Washington, D.C.)
|
October 13, 2021
Recommendations for Integrated Systems and Services for People With Co-occurring Mental Health and Substance Use Conditions
Kenneth Minkoff, Nancy H Covell
JAMA Psychiatry
|
June 3, 2026
Integrated Treatment Can Promote Recovery
Nancy H Covell, Kenneth Minkoff
Journal of Dual Diagnosis
|
October 22, 2014
Utility of Hair, Urine, and Self-Report to Monitor Drug Use in Research Studies including People with Schizophrenia
Nancy H Covell, Susan M Essock
Schizophrenia Bulletin
|
July 29, 2004
Weight gain with clozapine compared to first generation antipsychotic medications
Nancy H Covell, Ellen M Weissman, Susan M Essock
Psychiatric Services (Washington, D.C.)
|
December 1, 2020
COVID-19 Impact on Learning Among New York State Providers and Learners
Melissa T Hinds, Nancy H Covell, Devyn Wray-Scriven
Schizophrenia Bulletin
|
January 6, 2005
Inside the black box: the importance of monitoring treatment implementation
Susan M Essock, Nancy H Covell, Ellen M Weissman
Global Implementation Research and Applications
|
October 8, 2021
Applying Implementation Drivers to Scale-up Evidence-Based Practices in New York State
Paul J Margolies, Nancy H Covell, Sapana R Patel
The New England Journal of Medicine
|
January 21, 2006
Antipsychotic drugs and schizophrenia
Susan M Essock, Nancy H Covell, Carlos T Jackson
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Evidence-Based Mental Health
|
April 14, 2016
Long-acting injectable risperidone as an option in first-episode psychosis
Nancy H Covell
Evidence-Based Mental Health
|
January 30, 2009
Antipsychotic medications do not differ substantially in ability to reduce violent behaviour in people with schizophrenia
Nancy H Covell
Psychiatric Services (Washington, D.C.)
|
October 13, 2021
Recommendations for Integrated Systems and Services for People With Co-occurring Mental Health and Substance Use Conditions
Kenneth Minkoff, Nancy H Covell
JAMA Psychiatry
|
June 3, 2026
Integrated Treatment Can Promote Recovery
Nancy H Covell, Kenneth Minkoff
Journal of Dual Diagnosis
|
October 22, 2014
Utility of Hair, Urine, and Self-Report to Monitor Drug Use in Research Studies including People with Schizophrenia
Nancy H Covell, Susan M Essock
Schizophrenia Bulletin
|
July 29, 2004
Weight gain with clozapine compared to first generation antipsychotic medications
Nancy H Covell, Ellen M Weissman, Susan M Essock
Psychiatric Services (Washington, D.C.)
|
December 1, 2020
COVID-19 Impact on Learning Among New York State Providers and Learners
Melissa T Hinds, Nancy H Covell, Devyn Wray-Scriven
Schizophrenia Bulletin
|
January 6, 2005
Inside the black box: the importance of monitoring treatment implementation
Susan M Essock, Nancy H Covell, Ellen M Weissman
Global Implementation Research and Applications
|
October 8, 2021
Applying Implementation Drivers to Scale-up Evidence-Based Practices in New York State
Paul J Margolies, Nancy H Covell, Sapana R Patel
The New England Journal of Medicine
|
January 21, 2006
Antipsychotic drugs and schizophrenia
Susan M Essock, Nancy H Covell, Carlos T Jackson
Page
of 6